Sanjeev Chawla1, Emily Devlin2, Claudia Ianelli3, Deepa Thakuri1, Dushyant Kumar1, Hari Hariharan1, Suyash Mohan1, James Loughead2, Cynthia Neill Epperson3, Ravinder Reddy1, and Ravi Prakash Reddy Nanga1
1Department of Radiology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, United States, 2Department of Psychiatry, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, United States, 3University of Clorado School of Medicine, Aurora, CO, United States
Synopsis
The purpose was to evaluate the differential degree of
iron deposition in deep gray-matter regions in a healthy population of
cigarette smokers (n=8) and non-smokers (n=7) using quantitative susceptibility
mapping (QSM). All subjects underwent anatomical imaging and 3D-susceptibiluty
weighted imaging on a 7T MR system. A trend towards higher QSM was observed in
smokers than in non-smokers from globus pallidus region. All other DGM regions also
had higher QSM values in smokers compared to those of non-smokers, however, no
significant differences were observed. Future studies are warranted to validate
our findings in a larger cohort.
Introduction
Iron plays an important role in normal brain metabolism1. However, iron overload is known to initiate and
amplify a wave of oxidative injury eventually leading to neurodegeneration2.
A strong body of evidence3,4 has suggested that increased iron
deposition occurs within deep gray-matter (DGM) regions predominantly in basal
ganglia and thalamus of patients with neurodegenerative diseases. Moreover, progressive iron accumulation in different
structures of brain accompanies normal aging processes5. It is also
known that chronic, and
excessive alcohol consumption frequently leads to an abnormal buildup of iron
in liver, and brain6. However, impairment in brain iron
metabolism is poorly understood in a population of cigarette smokers. Ultra-high field strength quantitative
susceptibility mapping (QSM) offers a highly sensitive tool for iron detection
and quantification secondary to greater signal to noise ratio, spatial
resolution and tissue contrast7-9. The purpose of the present study
was to evaluate the differential degree of iron deposition in DGM nuclei in
population of cigarette smokers and non-smokers.Methods
A
cohort of 10 healthy self-reported non-smokers with expired breath carbon monoxide
(CO) of below 8ppm and 10 smokers with intake of atleast 5 cigarettes per day
for at least 2 years and expired breath CO level of >8ppm completed the MRI scans out of which
two subjects, one each in smokers and non-smokers did not had 3D-SWI data
acquired. All subjects underwent MR imaging on a
whole body 7.0T scanner (MAGNETOM Terra, Siemens Healthcare, Erlangen, Germany)
with a single volume coil transmit/32-channel receive proton head phased-array
coil. The imaging protocol included sagittal T1-weighted
3D-MPRAGE and axial 3D-susceptibility weighted imaging (SWI) sequences.
High-resolution, flow-compensated 3D-SWI images were acquired with the
following parameters: TR/TE=27/18ms, flip-angle=18°, slice thickness=2mm,
FOV=240×240mm2, base resolution=1024, voxel size=0.2×0.2×2mm3,
bandwidth=110Hz/px, iPAT factor=2 and acquisition time=7min:49sec. To avoid,
susceptibility artifacts from air-tissue interfaces, only supratentorial brain
regions were covered while acquiring 3D-SWI. Susceptibility weighted imaging
and mapping (SWIM) algorithm developed by Dr. Haacke’s group8 was used
to reconstruct QSM maps from high resolution 3D-SWI data. The post-processing
involved skull stripping to remove the artifacts caused by skull and brain
tissue interface using the brain extraction tool, followed by phase unwrapping
using a Laplacian operator. To remove background field in homogeneity, a
variable high-pass filter of 32 pixels size was applied and, finally, inverse
filtering was performed to generate QSM maps. The median QSM values
(in ppb) were computed from DGM regions (thalamus, putamen, globus pallidus,
and caudate nucleus) by manually drawing regions of interests (ROIs) on these
regions bilaterally. The QSM values from both cerebral hemispheres were averaged and were compared between non-smokers
and smokers using independent sample t-tests. A probability (p) value of less
than 0.05 was considered significant.Results
Representative QSM maps from non-smoker and smoker are
shown in Figure 1. Distributions of QSM values between two
groups of subjects are shown as box-whisker plots (Figure 2). Data presented here are from 15 subjects (7
non-smokers and 8 smokers) analyzed so far. A trend towards higher QSM was
observed in smokers (35.4 ± 8.7ppb vs. 27.5 ± 7.2ppb, p=0.08) than in
non-smokers from globus pallidus region. All other DGM regions also had higher
QSM values in smokers compared to those of non-smokers, however, no significant
differences were observed (p>0.10). Discussion
In this pilot study, we sought to determine the
differential degree of iron deposition in DGM regions between smokers and
non-smokers. Our initial findings suggest that smokers may accumulate increased
iron contents in different DGM regions of brain. Several studies9,10
including from our group11,12 have reported that impaired iron
metabolism is implicated in the pathogenesis of several neurodegenerative
disorders, cardiovascular and hepatic diseases. However, data on the association between lifestyle
factors, such as alcohol consumption, smoking, physical activity, and iron
overload are still limited and inconsistent. There have been controversial
findings on the association between smoking and iron status. One study reported
no difference in plasma iron levels between non-smokers and smokers.13
But, another study examined that pregnant women who had smoked had higher
ferritin levels in blood than those who had never smoked.14 While
assessing serum transferrin saturation (TSAT) levels, one study15 found
a positive relationship between heavy smoking > 10 cigarettes/day and iron
overload. To the best of our knowledge, no study has examined the abnormal
brain iron accumulation in a population of smokers. In the present study, we
observed a trend towards increased iron deposition in DGM regions in smokers
compared to those of non-smokers. Collectively, our findings and prior studies
provide a notion that there might be a potential association between heavy
smoking and iron overload. The molecular pathways for iron accumulation in brain
regions still remain to be fully understood, however, it has been
suggested that smoking may stimulate erythropoiesis in a dose-related manner
due to hypoxia, which is induced by smoking.16 Conclusion
Heavy smoking may
increase the risk of iron deposition in brain regions. However, future studies
are required to confirm our findings in a larger cohort. Acknowledgements
This project was supported by a pilot grant from The Thomas B. and Jeannette E. Laws McCabe Fund, National Institute of Biomedical Imaging and Bioengineering of the National Institute of Health through grant number p41-EB015893.References
1. Koeppen AH. A brief history of
brain iron research. J Neurol Sci 2003;207:95-97.
2.
Haider L. Inflammation, Iron, Energy Failure, and Oxidative
Stress in the Pathogenesis of Multiple Sclerosis. Oxidative medicine and
cellular longevity 2015;2015:725370.
3.
Acevedo
K, Masaldan S, Opazo CM, et al. Redox active metals in neurodegenerative
diseases. J Biol Inorg Chem. 2019 Oct 24. doi:
10.1007/s00775-019-01731-9.
4.
Levi
S, Cozzi A, Santambrogio P. Iron Pathophysiology in Neurodegeneration
with Brain Iron Accumulation. Adv Exp Med Biol.
2019;1173:153-77.
5.
Ghadery C, Pirpamer L, Hofer E, et al.
R2* mapping for brain iron: associations with cognition in
normal aging. Neurobiol Aging. 2015;36:925-32.
6.
Fletcher
LM. Alcohol and iron: one glass of red or more? J
Gastroenterol Hepatol. 1996 Nov;11(11):1039-41.
7.
Eskreis-Winkler
S, Deh K, Gupta A, et al. Multiple sclerosis lesion
geometry in quantitative susceptibility mapping (QSM) and phase imaging. J Magn Reson Imaging. 2015;42(1):224-9.
8.
Liu
S, Neelavalli J, Cheng YC, Tang J, Mark Haacke E. Quantitative susceptibility
mapping of small objects using volume constraints. Magn Reson Med. 2013;69:716–723.
9.
Yan
F, He N, Lin H, et al. Iron deposition quantification: Applications
in the brain and liver. J Magn Reson Imaging. 2018
Aug;48(2):301-317.
10. Kaindlstorfer C, Jellinger KA, Eschlböck
S, et al. The Relevance of Iron in the Pathogenesis of Multiple
System Atrophy: A Viewpoint. J Alzheimers Dis.
2018;61(4):1253-1273.
11. Chawla S, Kister I, Wuerfel J, et al.
Iron and Non-Iron-Related Characteristics of Multiple Sclerosis and
Neuromyelitis Optica Lesions at 7T MRI. Am J
Neuroradiol. 2016 Jul;37(7):1223-30.
12. Chawla S, Kister I, Sinnecker T, et al.
Longitudinal study of multiple sclerosis lesions using ultra-high field (7T)
multiparametric MR imaging. PLoS One. 2018 Sep
13;13(9):e0202918. doi: 10.1371/journal.pone.0202918. eCollection 2018.
13.
Kocyigit A, Erel O, Gur S. Effects of tobacco smoking on
plasma selenium, zinc, copper and iron concentrations and related antioxidative
enzyme activities. Clin Biochem. 2001;34:629–633.
14. Chełchowska M, Ambroszkiewicz J, Gajewska
J, et al. Hepcidin and iron metabolism in pregnancy: correlation with smoking
and birth weight and length. Biol Trace Elem
Res. 2016;173:14–20.
15. Kim H, Shin C, BaiK I .Association between
lifestyle factors and iron overload in Korean adults. Clin Nutr Res. 2016
Oct;5(4):270-278.
16. Ghio AJ, Hilborn ED, Stonehuerner JG, et
al. Particulate matter in cigarette smoke alters iron homeostasis to produce a
biological effect. Am J Respir Crit Care
Med. 2008;178:1130–1138.